Telangiectasis: Clinical Trials

33 trials for Telangiectasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

33 completed. 33 Phase 2, 5 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 233Completed 33
Phase 15Completed 5
Phase 31Completed 1

Follow Telangiectasis: new trials by email Literature Review of Telangiectasis trials Research Report on Telangiectasis

Trials (filtered) newest first · largest first

All 33 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Sirolimus Treatment in Pediatric Patients With Ataxia-Telangiectasia
Rapamune (sirolimus/rapamycin) - Ataxia-Telangiectasia (A-T), Ataxia-Telangiectasia
Phase 2CompletedSara Elva Espinosa Padilla, MD62024-07-112026-09-15
Effects of Pazopanib on Hereditary Hemorrhagic Telangiectasia Related Epistaxis and Anemia (Paz)
Pazopanib, Placebo oral capsule - Hereditary Hemorrhagic Telangiectasia, Epistaxis
Phase 2 / Phase 3CompletedCure HHT712023-05-082026-10-27
Sirolimus for Nosebleeds in HHT
Sirolimus - Hereditary Hemorrhagic Telangiectasia, Nosebleeds
Phase 2CompletedUnity Health Toronto102022-03-162026-06-04
Ataxia-telangiectasia: Treating Mitochondrial Dysfunction With a Novel Form of Anaplerosis
Triheptanoin - Ataxia Telangiectasia
Phase 2CompletedThe University of Queensland302022-03-152023-07-20
Tacrolimus Trial for Hereditary Hemorrhagic Telangiectasia (HHT)
Tacrolimus capsule (low-dose) - Hereditary Hemorrhagic Telangiectasia, Epistaxis Nosebleed
Phase 2CompletedUnity Health Toronto102020-10-202025-04-01
Efficacy of Nintedanib Per os as a Treatment for Epistaxis in HHT Disease.
Nintedanib 150 mg and 100 mg soft capsules, Oral treatment of placebo soft capsule - Telangiectasia, Hereditary Hemorrhagic, Rendu Osler Disease
Phase 2CompletedHospices Civils de Lyon612020-06-222025-08-01
Timolol Gel for Epistaxis in Hereditary Hemorrhagic Telangiectasia
Timolol Gel, Placebo Gel - Hereditary Hemorrhagic Telangiectasia
Phase 2CompletedWashington University School of Medicine272019-10-202021-08-24
Pomalidomide for the Treatment of Bleeding in HHT
Pomalidomide Oral Product, Placebo oral capsule - Telangiectasia, Hereditary Hemorrhagic
Phase 2CompletedThe Cleveland Clinic1452019-10-172024-10-23
Effects of Vitamin B3 in Patients With Ataxia Telangiectasia
Vitamin B3 - Ataxia Telangiectasia, ATM Gene Mutation
Phase 2CompletedRadboud University Medical Center242019-03-182022-07-25
A Study to Evaluate THR-317 Treatment for Macular Telangiectasia Type 1 (MacTel 1)
THR-317 8mg - Retinal Telangiectasis, Idiopathic Juxtafoveal Retinal Telangiectasia
Phase 2CompletedThromboGenics82018-09-182020-09-02
Doxycycline for Hereditary Hemorrhagic Telangiectasia
Doxycycline Hyclate, Placebo - Hereditary Hemorrhagic Telangiectasia (HHT)
Phase 2CompletedUnity Health Toronto132018-09-122025-04-01
Efficacy and Safety of a 0.1% Tacrolimus Nasal Ointment as a Treatment for Epistaxis in Hemorrhagic Hereditary Telangiectasia (HHT)
Protopic® (Tacrolimus) 0.1% ointment, Placebo - Hemorrhagic Hereditary Telangiectasia (HHT)
Phase 2CompletedHospices Civils de Lyon502017-05-222020-07-01
Efficacy of a Timolol Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) - (TEMPO)
Timolol nasal spray, Placebo nasal spray - Telangiectasia, Hereditary Hemorrhagic, Osler Rendu Disease
Phase 2CompletedHospices Civils de Lyon582015-06-012025-08-08
Treatment of Hereditary Hemorrhagic Telangiectasia of the Nasal Mucosa by Intranasal Bevacizumab : Search for Effective Dose
bevacuzimab spray - Telangiectasia, Hereditary Hemorrhagic
Phase 1 / Phase 2CompletedUniversity Hospital, Caen202014-12-152026-07-30
Evaluation of the Tolerability of Switching Subjects on Chronic ATC Opioid Therapy to Buprenorphine HCl Buccal Film
Buprenorphine, Placebo film, Oxycodone - Pain
Phase 2CompletedBioDelivery Sciences International392013-06-012017-02-27
Topical Anti-angiogenic Therapy for Telangiectasia in HHT: Proof of Concept
Topical timolol maleate, placebo saline drops - Hereditary Hemorrhagic Telangiectasia
Phase 1 / Phase 2CompletedUnity Health Toronto52013-05-012023-09-21
Comparison Between Two Different Parameters of Argon Plasma Coagulation in the Treatment of Chronic Radiation Proctitis: Historical Control Trial.
Argon Plasma Coagulation, Historical control - Radiation Injuries, Telangiectasis
Phase 2CompletedBarretos Cancer Hospital412013-01-012015-08-27
Efficacy of Thalidomide in the Treatment of Hereditary Hemorrhagic Telangiectasia
Thalidomide - Hereditary Hemorrhagic Telangiectasia, Epistaxis
Phase 2CompletedFondazione IRCCS Policlinico San Matteo di Pavia312011-11-012017-08-29
North American Study of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
Sterile saline, Bevacizumab, Estriol - Telangiectasia, Hereditary Hemorrhagic, Epistaxis
Phase 2CompletedJames Gossage1232011-08-012018-10-19
Intranasal Submucosal Bevacizumab for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
Bevacizumab, NaCl - HHT, Morbus Osler
Phase 2CompletedMedical University of Vienna152011-03-012013-08-12

Showing 20 of 33. Sign in to see all of them.

Narrower conditions

Telangiectasia, Hereditary Hemorrhagic (21)  ·  Epistaxis (11)  ·  Ataxia Telangiectasia (5)  ·  Retinal Telangiectasis (3)  ·  Gastrointestinal Hemorrhage (2)  ·  Rosacea (2)  ·  Acne Vulgaris (1)  ·  Anemia (1)  ·  Angiodysplasia (1)  ·  Arteriovenous Malformations (1)  ·  Ataxia (1)  ·  Blast Crisis (1)  ·  Breast Neoplasms (1)  ·  Burkitt Lymphoma (1)

Broader conditions

Cardiovascular Diseases (33)  ·  Vascular Diseases (33)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (27)  ·  Congenital Abnormalities (23)  ·  Hemic and Lymphatic Diseases (23)  ·  Hemorrhagic Disorders (23)  ·  Hemostatic Disorders (23)  ·  Hematologic Diseases (22)  ·  Cardiovascular Abnormalities (21)  ·  Vascular Malformations (20)  ·  Pathological Conditions, Signs and Symptoms (19)  ·  Pathologic Processes (16)  ·  Signs and Symptoms (14)  ·  Hemorrhage (13)

Interventions

Bevacizumab (5)  ·  Ranibizumab (2)  ·  Sirolimus (2)  ·  Tacrolimus (2)  ·  Thalidomide (2)  ·  Argon Plasma Coagulation (1)  ·  Buprenorphine (1)  ·  Capsules (1)  ·  Caspofungin (1)  ·  Cellulose (1)  ·  Doxycycline (1)  ·  Estriol (1)  ·  Estrogens (1)  ·  Historically Controlled Study (1)  ·  Lasers, Gas (1)

Sponsors

Hospices Civils de Lyon (4)  ·  Unity Health Toronto (4)  ·  Manhattan Eye, Ear & Throat Hospital (2)  ·  University of California, San Diego (2)  ·  Barretos Cancer Hospital (1)  ·  BioDelivery Sciences International (1)  ·  Cure HHT (1)  ·  European Organisation for Research and Treatment of Cancer - EORTC (1)  ·  Eye Center of Northern Colorado, P.C. (1)  ·  Fondazione IRCCS Policlinico San Matteo di Pavia (1)  ·  James Gossage (1)  ·  Julian M. Mackay-Wiggan (1)  ·  Medical University of Vienna (1)  ·  National Center for Research Resources (NCRR) (1)  ·  Northport Veterans Affairs Medical Center (1)

Countries

United States (14)  ·  France (7)  ·  Canada (4)  ·  Italy (2)  ·  Switzerland (2)  ·  Australia (1)  ·  Austria (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Germany (1)  ·  Israel (1)  ·  Mexico (1)  ·  Netherlands (1)  ·  Slovakia (1)  ·  Turkey (Türkiye) (1)

Top investigators

Marie E Faughnan, MD MSc FRCPC (3)  ·  James Gossage, MD (2)  ·  Lawrence A. Yannuzzi, MD (2)  ·  Arthur Korotkin, M.D. (1)  ·  Atul Kumar, MD (1)  ·  Carlo Balduini, M.D. (1)  ·  Claudio Viscoli, MD (1)  ·  David Coman, MBBS FRACP (1)  ·  Eitan Yaniv, MD (1)  ·  Gerald D Weinstein, MD (1)  ·  Holly Boyer, MD (1)  ·  James R Gossage, MD (1)  ·  Jay F Piccirillo, MD (1)

Results publications

PMID 16763896, PMID 16934683, PMID 19841031, PMID 22144182, PMID 22396517, PMID 22875082, PMID 22927201, PMID 24236946, PMID 24595923, PMID 25656498, PMID 26433381, PMID 26547562, PMID 26686256, PMID 26851119, PMID 27599329, PMID 28871440, PMID 28969699, PMID 29110179, PMID 30191360, PMID 30586396, PMID 30796268, PMID 30948626, PMID 31427745, PMID 32940653, PMID 33437944, PMID 36344987, PMID 39292928, PMID 39510938, PMID 39718659, PMID 41719457

NIH funding

2017 (2), 2009 (1), 2015 (1), 2019 (1), U54NS065705 (1)